Calibr, A Division Of Scripps Research

This early-stage study tested a new drug called PDM608 in 64 healthy adults to see if it is safe and how the body processes it. The goal was not to treat Parkinson's disease yet, but to gather important safety information before testing it in patients. Participants received eithe…

This study followed 16 people who had already received a special immune cell treatment (CLBR001 CAR-T) for various types of B-cell blood cancers like lymphoma and leukemia. The goal was to check for any new or long-term side effects that might appear months or years after treatme…